Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism

References

• SingerDEAlbersGWDalenJEAntithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest20081336 Suppl546S592S18574273
   PubMed Web of Science ®Google Scholar
• SalemDNO’GaraPTMadiasCPaukerSGAmerican College of Chest PhysiciansValvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest20081336 Suppl593S629S18574274
   PubMed Web of Science ®Google Scholar
• KearonCKahnSRAgnelliGAntithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest20081336 Suppl454S545S18574272
   PubMed Web of Science ®Google Scholar
• FanikosJStapinskiCKooSKucherNTsilimingrasKGoldhaberSZMedication errors associated with anticoagulant therapy in the hospitalAm J Cardiol200494453253515325949
   PubMed Web of Science ®Google Scholar
• The 5 million lives campaign. http://www.ihi.org/IHI/Programs/Campaign/ Updated 2009. Accessed December 1, 2009.
   Google Scholar
• StaffordRSSingerDENational patterns of warfarin use in atrial fibrillationArch Intern Med199615622253725418951296
   PubMedGoogle Scholar
• GoASHylekEMBorowskyLHPhillipsKASelbyJVSingerDEWarfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) studyAnn Intern Med19991311292793410610643
   PubMed Web of Science ®Google Scholar
• KutnerMNixonGSilverstoneFPhysicians’ attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillationArch Intern Med199115110195019531929682
   PubMedGoogle Scholar
• EzekowitzMDFalkRHThe increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillationMayo Clin Proc200479790491315244388
   PubMed Web of Science ®Google Scholar
• MinichielloTFogartyPFDiagnosis and management of venous thromboembolismMed Clin North Am200892244365x18298988
   PubMed Web of Science ®Google Scholar
• GoASHylekEMPhillipsKAPrevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyJAMA2001285182370237511343485
   PubMed Web of Science ®Google Scholar
• FeinbergWMBlackshearJLLaupacisAKronmalRHartRGPrevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implicationsArch Intern Med199515554694737864703
   PubMedGoogle Scholar
• WolfPASingerDEPreventing stroke in atrial fibrillationAm Fam Physician1997569224222509402810
   PubMed Web of Science ®Google Scholar
• WolfPAAbbottRDKannelWBAtrial fibrillation: a major contributor to stroke in the elderly. The Framingham StudyArch Intern Med19871479156115643632164
   PubMedGoogle Scholar
• Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trialsArch Intern Med199415413144914578018000
   PubMed Web of Science ®Google Scholar
• PetersenPBoysenGGodtfredsenJAndersenEDAndersenBPlacebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK studyLancet1989186311751792563096
   PubMed Web of Science ®Google Scholar
• EzekowitzMDBridgersSLJamesKEWarfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation InvestigatorsN Engl J Med199232720140614121406859
   PubMed Web of Science ®Google Scholar
• ConnollySJLaupacisAGentMRobertsRSCairnsJAJoynerCCanadian Atrial Fibrillation Anticoagulation (CAFA) StudyJ Am Coll Cardiol19911823493551856403
   PubMed Web of Science ®Google Scholar
• Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study GroupLancet19933428882125512627901582
   PubMed Web of Science ®Google Scholar
• The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation InvestigatorsN Engl J Med199032322150515112233931
   PubMed Web of Science ®Google Scholar
• Stroke Prevention in Atrial Fibrillation Study. Final resultsCirculation19918425275391860198
   PubMed Web of Science ®Google Scholar
• HeitJAMeltonLJ3rdLohseCMIncidence of venous thromboembolism in hospitalized patients vs community residentsMayo Clin Proc200176111102111011702898
   PubMed Web of Science ®Google Scholar
• WhiteRHThe epidemiology of venous thromboembolismCirculation200310723 Suppl 1I4812814979
   PubMed Web of Science ®Google Scholar
• SilversteinMDHeitJAMohrDNPettersonTMO’FallonWMMeltonLJ3rdTrends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based studyArch Intern Med199815865855939521222
   PubMed Web of Science ®Google Scholar
• HorlanderKTManninoDMLeeperKVPulmonary embolism mortality in the United States, 1979–1998 an analysis using multiple-cause mortality dataArch Intern Med2003163141711171712885687
   PubMed Web of Science ®Google Scholar
• LevineMNHirshJGentMOptimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosisThromb Haemost19957426066118584992
   PubMed Web of Science ®Google Scholar
• SchulmanSRhedinASLindmarkerPA comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study GroupN Engl J Med199533225166116657760866
   PubMed Web of Science ®Google Scholar
• PrandoniPLensingAWPrinsMHResidual venous thrombosis as a predictive factor of recurrent venous thromboembolismAnn Intern Med20021371295596012484710
   PubMed Web of Science ®Google Scholar
• GrifoniSVanniSMagazziniSAssociation of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic eventsArch Intern Med2006166192151215617060547
   PubMedGoogle Scholar
• Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation InvestigatorsArch Intern Med199615644094168607726
   PubMedGoogle Scholar
• A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study GroupAnn Neurol19974268578659403477
   PubMed Web of Science ®Google Scholar
• GorterJWMajor bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groupsNeurology19995361319132710522891
   PubMed Web of Science ®Google Scholar
• HylekEMGoASChangYEffect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillationN Engl J Med2003349111019102612968085
   PubMed Web of Science ®Google Scholar
• KearonCGinsbergJSKovacsMJComparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for longterm prevention of recurrent venous thromboembolismN Engl J Med2003349763163912917299
   PubMed Web of Science ®Google Scholar
• MatcharDBSamsaGPCohenSJOddoneEZJurgelskiAEImproving the quality of anticoagulation of patients with atrial fibrillation in managed care organizations: results of the managing anticoagulation services trialAm J Med20021131425112106622
   PubMed Web of Science ®Google Scholar
• GallagherAMRietbrockSPlumbJvan StaaTPInitiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?J Thromb Haemost2008691500150618573187
   PubMed Web of Science ®Google Scholar
• MantJHobbsFDFletcherKWarfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trialLancet2007370958649350317693178
   PubMed Web of Science ®Google Scholar
• HylekEMEvans-MolinaCSheaCHenaultLEReganSMajor hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillationCirculation2007115212689269617515465
   PubMed Web of Science ®Google Scholar
• De SchryverELvan GijnJKappelleLJKoudstaalPJAlgraADutch TIA trial and SPIRIT study groupsNon-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic strokeJ Neurol2005252111316132115868068
   PubMed Web of Science ®Google Scholar
• AnsellJHirshJHylekEPharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Chest20081336 Suppl160S198S18574265
   PubMed Web of Science ®Google Scholar
• GageBFCardinalliABOwensDKThe effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of lifeArch Intern Med199615616182918368790077
   PubMed Web of Science ®Google Scholar
• DasAKAhmedACorradoOJWestRMQuality of life of elderly people on warfarin for atrial fibrillationAge Ageing20093875175419710070
   PubMed Web of Science ®Google Scholar
• PrinsMHMarrelACaritaPMultinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the ‘Perception of Anticoagulant Treatment Questionnaire’ (PACT-Q)Health Qual Life Outcomes20097919196486
   PubMed Web of Science ®Google Scholar
• DantasGCThompsonBVMansonJATracyCSUpshurREPatients’ perspectives on taking warfarin: qualitative study in family practiceBMC Fam Pract200451515268764
   PubMedGoogle Scholar
• DevereauxPJAndersonDRGardnerMJDifferences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational studyBMJ200132373231218122211719412
   PubMed Web of Science ®Google Scholar
• ProtheroeJFaheyTMontgomeryAAPetersTJThe impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysisBMJ200032072461380138410818030
   PubMed Web of Science ®Google Scholar
• LancasterTRSingerDESheehanMAThe impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation InvestigatorsArch Intern Med199115110194419491929681
   PubMedGoogle Scholar
• DasAKWillcoxsonPDCorradoOJWestRMThe impact of long-term warfarin on the quality of life of elderly people with atrial fibrillationAge Ageing2007361959716799180
   PubMed Web of Science ®Google Scholar
• LocadiaMSprangersMAde HaesHCBullerHRPrinsMHQuality of life and the duration of treatment with vitamin K antagonists in patients with deep venous thrombosisThromb Haemost200390110110712876632
   PubMed Web of Science ®Google Scholar
• DavisNJBillettHHCohenHWArnstenJHImpact of adherence, knowledge, and quality of life on anticoagulation controlAnn Pharmacother200539463263615713790
   PubMed Web of Science ®Google Scholar
• SweeneyKGGrayDPSteeleREvansPUse of warfarin in nonrheumatic atrial fibrillation: a commentary from general practiceBr J Gen Pract1995453921531587772394
   PubMed Web of Science ®Google Scholar
• HednerECarlssonJKulichKRStigendalLIngelgardAWiklundIAn instrument for measuring health-related quality of life in patients with Deep Venous Thrombosis (DVT): development and validation of Deep Venous Thrombosis Quality of Life (DVTQOL) questionnaireHealth Qual Life Outcomes200423015214965
   PubMedGoogle Scholar
• SamsaGMatcharDBDolorRJA new instrument for measuring anticoagulation-related quality of life: development and preliminary validationHealth Qual Life Outcomes200422215132746
   PubMedGoogle Scholar
• ACTIVE Writing Group of the ACTIVE InvestigatorsConnollySPogueJClopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trialLancet200636795261903191216765759
   PubMed Web of Science ®Google Scholar
• OlssonSBExecutive Steering Committee of the SPORTIF III InvestigatorsStroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trialLancet200336293971691169814643116
   PubMed Web of Science ®Google Scholar
• AlbersGWDienerHCFrisonLXimelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trialJAMA2005293669069815701910
   PubMed Web of Science ®Google Scholar
• ConnollySJEzekowitzMDYusufSDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• SchulmanSKearonCKakkarAKDabigatran versus warfarin in the treatment of acute venous thromboembolismN Engl J Med2009361242342235219966341
   PubMed Web of Science ®Google Scholar
• FangMCStaffordRSRuskinJNSingerDENational trends in antiarrhythmic and antithrombotic medication use in atrial fibrillationArch Intern Med20041641556014718322
   PubMed Web of Science ®Google Scholar
• GageBFBoechlerMDoggetteALAdverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillationStroke200031482282710753982
   PubMed Web of Science ®Google Scholar
• WalkerAMBennettDEpidemiology and outcomes in patients with atrial fibrillation in the United StatesHeart Rhythm20085101365137218929320
   PubMed Web of Science ®Google Scholar
• JohnstonJACluxtonRJJrHeatonPCGuoJJMoomawCJEckmanMHPredictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillationArch Intern Med2003163141705171012885686
   PubMedGoogle Scholar
• BungardTJGhaliWATeoKKMcAlisterFATsuyukiRTWhy do patients with atrial fibrillation not receive warfarin?Arch Intern Med20001601414610632303
   PubMedGoogle Scholar
• GoASHylekEMBorowskyLHPhillipsKASelbyJVSingerDEWarfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) studyAnn Intern Med19991311292793410610643
   PubMed Web of Science ®Google Scholar
• CavallariLHAstonJLMomaryKMShapiroNLPatelSRNutescuEAPredictors of unstable anticoagulation in African AmericansJ Thromb Thrombolysis200927443043718563532
   PubMed Web of Science ®Google Scholar
• WatermanADMilliganPEBayerLBanetGAGatchelSKGageBFEffect of warfarin nonadherence on control of the International Normalized RatioAm J Health Syst Pharm200461121258126415259756
   PubMed Web of Science ®Google Scholar
• PalaretiGLegnaniCGuazzalocaGRisks factors for highly unstable response to oral anticoagulation: a case-control studyBr J Haematol20051291727815801958
   PubMed Web of Science ®Google Scholar
• LaporteSQuenetSBuchmuller-CordierACompliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trialThromb Haemost200389345846712624628
   PubMed Web of Science ®Google Scholar
• WhiteHDGruberMFeyziJComparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and VArch Intern Med2007167323924517296878
   PubMedGoogle Scholar
• FangMCGoASChangYPredictors of warfarin discontinuation in older patients with atrial fibrillationJ Am Coll Cardiol200851A238
   Web of Science ®Google Scholar
• ArnstenJHGelfandJMSingerDEDeterminants of compliance with anticoagulation: A case-control studyAm J Med1997103111179236480
   PubMed Web of Science ®Google Scholar
• KimmelSEChenZPriceMThe influence of patient adherence on anticoagulation control with warfarin: results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) StudyArch Intern Med2007167322923517296877
   PubMed Web of Science ®Google Scholar
• PlattABLocalioARBrensingerCMRisk factors for nonadherence to warfarin: results from the IN-RANGE studyPharmacoepidemiol Drug Saf200817985386018271059
   PubMed Web of Science ®Google Scholar
• PlattABLocalioARBrensingerCMRisk factors for nonadherence to warfarin: results from the IN-RANGE studyPharmacoepidemiol Drug Saf200817985386018271059
   PubMed Web of Science ®Google Scholar
• FangMCMachtingerELWangFSchillingerDHealth literacy and anticoagulation-related outcomes among patients taking warfarinJ Gen Intern Med200621884184616881944
   PubMed Web of Science ®Google Scholar
• EdigerJPWalkerJRGraffLPredictors of medication adherence in inflammatory bowel diseaseAm J Gastroenterol200710271417142617437505
   PubMed Web of Science ®Google Scholar
• BosworthHBDudleyTOlsenMKRacial differences in blood pressure control: potential explanatory factorsAm J Med2006119170.e970.e1516431192
   PubMedGoogle Scholar
• Perez-StableEJSalazarRIssues in achieving compliance with antihypertensive treatment in the Latino populationClin Cornerstone2004634961 discussion 62–64.15707262
   PubMedGoogle Scholar
• RajiMAKuoYFSalazarJASatishSGoodwinJSEthnic differences in antihypertensive medication use in the elderlyAnn Pharmacother200438220921414742752
   PubMed Web of Science ®Google Scholar
• Birman-DeychERadfordMJNilasenaDSGageBFUse and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillationStroke20063741070107416528001
   PubMed Web of Science ®Google Scholar
• ShenAYYaoJFBrarSSJorgensenMBChenWRacial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillationJ Am Coll Cardiol200750430931517659197
   PubMed Web of Science ®Google Scholar
• WangPSBohnRLKnightEGlynnRJMogunHAvornJNoncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factorsJ Gen Intern Med200217750451112133140
   PubMed Web of Science ®Google Scholar
• SchauerDPMoomawCJWessMWebbTEckmanMHPsychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarinJ Gen Intern Med200520121114111916423100
   PubMed Web of Science ®Google Scholar
• NikolausTKruseWBachMSpecht-LeibleNOsterPSchlierfGElderly patients’ problems with medication. An in-hospital and follow-up studyEur J Clin Pharmacol19964942552598857069
   PubMed Web of Science ®Google Scholar
• SchillingerDWangFRodriguezMBindmanAMachtingerELThe importance of establishing regimen concordance in preventing medication errors in anticoagulant careJ Health Commun200611655556716950728
   PubMed Web of Science ®Google Scholar
• OrenskyIAHoldfordDAPredictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinicPharmacotherapy200525121801180816305299
   PubMed Web of Science ®Google Scholar
• CruessDGLocalioARPlattABPatient Attitudinal and Behavioral Factors Associated with Warfarin Non-adherence at Outpatient Anticoagulation ClinicsInt J Behav Med2009
   Web of Science ®Google Scholar
• GarciaDLibbyECrowtherMAThe new oral anticoagulantsBlood20101151152019880491
   PubMed Web of Science ®Google Scholar
• NochowitzBShapiroNLNutescuEACavallariLHEffect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic populationAnn Pharmacother20094371165117219549747
   PubMed Web of Science ®Google Scholar
• OakeNvan WalravenCRodgerMAForsterAJEffect of an interactive voice response system on oral anticoagulant managementCMAJ2009180992793319398739
   PubMed Web of Science ®Google Scholar
• VolppKGLoewensteinGTroxelABA test of financial incentives to improve warfarin adherenceBMC Health Serv Res2008827219102784
   PubMed Web of Science ®Google Scholar
• FitzmauriceDAMurrayETMcCahonDSelf management of oral anticoagulation: randomised trialBMJ20053317524105716216821
   PubMed Web of Science ®Google Scholar
• FitzmauriceDAGardinerCKitchenSAn evidence-based review and guidelines for patient self-testing and management of oral anticoagulationBr J Haematol2005131215616516197444
   PubMed Web of Science ®Google Scholar
• MazorKMBarilJDuganESpencerFBurgwinklePGurwitzJHPatient education about anticoagulant medication: is narrative evidence or statistical evidence more effectivePatient Educ Couns2007691314515717996788
   PubMed Web of Science ®Google Scholar
• HolbrookALabirisRGoldsmithCHOtaKHarbSSebaldtRJInfluence of decision aids on patient preferences for anticoagulant therapy: a randomized trialCMAJ2007176111583158717515584
   PubMed Web of Science ®Google Scholar